Changes in pattern electroretinogram after application of 0.01% atropine eye drops

Dear Sir, We want to report a profound, reversible reduction in p50 (N35–p50) amplitude in the pattern Electroretinogram (PERG) of eyes treated with low dose (0.01%) atropine eye drops without a significant change in the implicit time. [1] Potential side effects of topical atropine eye drops include...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Indian journal of ophthalmology 2019-02, Vol.67 (2), p.309-310
Hauptverfasser: Kothari, Mihir, Bhat, Deepak, Khadse, Nitu, Jain, Rishika, Rathod, Vivek, Aru, Pallavi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Dear Sir, We want to report a profound, reversible reduction in p50 (N35–p50) amplitude in the pattern Electroretinogram (PERG) of eyes treated with low dose (0.01%) atropine eye drops without a significant change in the implicit time. [1] Potential side effects of topical atropine eye drops include pupillary mydriasis, reduced accommodation, light sensitivity, near vision blur, headache, ocular allergy, periocular dermatitis, angle closure glaucoma, drug-related retinal toxicity, and mydriasis-related phototoxicity. The investigators of Atropine in the Treatment of Myopia studies have reported a lack of retinal toxicity with long term (2 years) use of atropine eye drops in children with progressive myopia using multifocal ERG (MFERG) testing.
ISSN:0301-4738
1998-3689
DOI:10.4103/ijo.IJO_989_18